← Back to Clinical Trials
Recruiting NCT06676332

NCT06676332 Effect of Multisensory Motor Imagery Training on Muscle Performance and Coordination in Children With Spastic Diplegia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06676332
Status Recruiting
Phase
Sponsor Cairo University
Condition Spastic Diplegia
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-11-16
Primary Completion 2025-02

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
motor imagery trainingtraditional physical therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-11-16 with a primary completion date of 2025-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

PURPOSE: The current study aims to: * Determine the effect of multisensory motor imagery training on muscle performance including (peak torque, work, power) of trunk and knee flexors and extensors in children with spastic diplegia. * Determine the effect of multisensory motor imagery training on coordination, strength and agility in children with spastic diplegia. BACKGROUND: Multisensory motor imagery training has an effect on muscle performance and coordination in children with spastic diplegia HYPOTHESES: There will be no effect of multisensory motor imagery training on muscle performance, coordination and strength and agility in children with spastic diplegic CP. RESEARCH QUESTION: Is there an effect of multisensory motor imagery training on coordination, strength and agility in children with spastic diplegia?

Eligibility Criteria

Inclusion Criteria: * Their age will be ranged from 8-12 years. * Mild degree of spasticity ranged from 1 to 1+ according to Modified Ashworth Scale * Their motor function will be at level I and II according to Gross Motor Function Classification System GMFCS * They will be able to follow instructions during evaluation and treatment. Exclusion Criteria: * \- Cardiovascular or respiratory disorders. * Botulinium muscular injection in the last 6 months * Surgical interference in lower limbs and/or spine. * Muscloskeletal problems or fixed deformities in the spine and/or lower extremities. * Seizures. * Visual or hearing impairment

Contact & Investigator

Central Contact

Mayada Elshahawy

✉ myadashahawy11@gmail.com

📞 0201095022909

Frequently Asked Questions

Who can join the NCT06676332 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 12 Years, studying Spastic Diplegia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06676332 currently recruiting?

Yes, NCT06676332 is actively recruiting participants. Contact the research team at myadashahawy11@gmail.com for enrollment information.

Where is the NCT06676332 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06676332 clinical trial?

NCT06676332 is sponsored by Cairo University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology